Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a meta-analysis

被引：0
|
作者：
Savarese, G. [1 ]
Giugliano, R. P. [2 ]
Rosano, G. M. C. [3 ]
Mcmurray, J. [4 ]
Magnani, G. [2 ]
Filippatos, G. [5 ]
Lund, L. H. [6 ]
Trimarco, B. [1 ]
Perrone-Filardi, P. [1 ]
机构：
[1] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy
[2] Brigham & Womens Hosp, TIMI Study Grp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA
[3] St Georges Univ London, Cardiovasc & Cell Sci Res Inst, London, England
[4] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[5] Attikon Univ Hosp, Athens, Greece
[6] Karolinska Inst, Dept Med, Cardiol Unit, Stockholm, Sweden
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P914
引用
收藏
页码：206 / 206
页数：1
相关论文
共 50 条
  • [21] Meta-analysis of the safety and efficacy of using minimally interrupted novel oral anticoagulants in patients undergoing catheter ablation for atrial fibrillation
    Mao, Yin-jun
    Wang, Hang
    Huang, Pin-fang
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2021, 60 (03) : 407 - 417
  • [22] Efficacy and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Liver Disease: a Meta-Analysis and Systematic Review
    Huang, Zhi-Chun
    Li, Chang-Qing
    Liu, Xiao-Yu
    Cao, Zhong-Chao
    Jia, Hai-Yu
    Dong, Ying
    Liu, Tian-Long
    Sun, Jian-jun
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (06) : 1205 - 1215
  • [23] The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
    Sohil Elfar
    Somaya Abdulbaset Mahmoud
    Samar Hamdi
    Aya Ahmed Emad
    Mohamed Abd-ElGawad
    Nouran A. Taha
    BMC Cardiovascular Disorders, 24
  • [24] Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
    Ruff, Christian T.
    Giugliano, Robert P.
    Braunwald, Eugene
    Hoffman, Elaine B.
    Deenadayalu, Naveen
    Ezekowitz, Michael D.
    Camm, A. John
    Weitz, Jeffrey I.
    Lewis, Basil S.
    Parkhomenko, Alexander
    Yamashita, Takeshi
    Antman, Elliott M.
    LANCET, 2014, 383 (9921): : 955 - 962
  • [25] THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Miller, Corey S.
    Grandi, Sonia
    Shimony, Avi
    Filion, Kristian
    Eisenberg, Mark
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E604 - E604
  • [26] Efficacy and safety of different oral anticoagulants for stroke prevention in older patients with atrial fibrillation: A network meta-analysis
    Zhang, Han
    Liu, Feng
    Lu, Xueli
    MEDICINE, 2024, 103 (42)
  • [27] Efficacy and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Liver Disease: a Meta-Analysis and Systematic Review
    Zhi-Chun Huang
    Chang-Qing Li
    Xiao-Yu Liu
    Zhong-Chao Cao
    Hai-Yu Jia
    Ying Dong
    Tian-Long Liu
    Jian-jun Sun
    Cardiovascular Drugs and Therapy, 2021, 35 : 1205 - 1215
  • [28] The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
    Elfar, Sohil
    Mahmoud, Somaya Abdulbaset
    Hamdi, Samar
    Emad, Aya Ahmed
    Abd-ElGawad, Mohamed
    Taha, Nouran A.
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01)
  • [29] Efficacy and Safety of Oral Anticoagulants for Atrial Fibrillation Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
    Rhee, Tae-Min
    Lee, So-Ryoung
    Choi, Eue-Keun
    Oh, Seil
    Lip, Gregory Y. H.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [30] Meta-analysis of Efficacy and Safety of the New Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation
    Jia, Bin
    Lynn, Henry S.
    Rong, Fen
    Zhang, Wei
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2014, 64 (04) : 368 - 374
12345